Toward evidence‐based medical statistics: a Bayesian analysis of double‐blind placebo‐controlled antidepressant trials in the treatment of anxiety disorders

摘要

The Food and Drug Administration (FDA) uses a  p‐values and the FDA conclusion categories. BFs ranged from 0.07 to 131,400, indicating a range of no support of evidence to strong evidence for the efficacy. Results also indicate a varying strength of evidence between the trials with  Copyright © 2016 John Wiley & Sons, Ltd.